Navigation Links
China Medical Technologies Reports Financial Results for Fourth Fiscal Quarter and Full Year ended March 31, 2010
Date:6/4/2010

Interest expense on convertible notes was RMB34.8 million (US$5.1 million) for 4Q FY2009. As of March 31, 2010, the Company's outstanding convertible notes of US$150.0 million and US$264.8 million bear interest at 3.5% and 4.0% per annum, respectively and will mature in November 2011 and August 2013, respectively. Due to the adoption of new authoritative guidance governing the accounting for convertible instruments that can be settled in cash or partially in cash upon conversion effective on April 1, 2009, the Company recorded additional non-cash interest expense of RMB7.6 million (US$1.1 million) for the US$150.0 million 3.5% convertible notes in 4Q FY2009. The Company also made an adjustment related to these convertible notes for the corresponding period of FY2008 by increasing non-cash interest expense by RMB7.2 million to adopt this guidance retrospectively. This new guidance is not applicable to the US$264.8 million 4% convertible notes.

Interest expense on amortization of convertible notes issuance costs was RMB4.3 million (US$0.6 million) for 4Q FY2009.

Other income was RMB26.3 million (US$3.8 million) for 4Q FY2009. The significant year-over-year increase was primarily due to the gain from the purchase of the Company's convertible notes on the open market.

Income tax expense was RMB15.2 million (

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 1, 2015  Research Solutions, Inc. (OTCQB: RSSS), a pioneer ... (STM) information for life science companies, academic institutions, and ... at the LD Micro Invitational being held on June ... Los Angeles . ... June 3rd at 9:30 a.m. Pacific time, with one-on-one ...
(Date:6/1/2015)... 2015  Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today ... as ,nal-IRI, in a Phase 1 investigator-sponsored study at ... Data were presented at the 2015 American Society of ... IL. Results from this study show a ... glioma when given intravenously.  Based in part ...
(Date:6/1/2015)... 2015 About Pressure Relief ... area and improve the quality life of patients who ... play a significant role in inhibiting the growth and ... to turn or rotate an immobile patient by providing ... overlay, and specialty beds. These devices have the ability ...
Breaking Medicine Technology:Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3
... MOUNTAIN VIEW, Calif., July 20, 2011 Concentric Medical, ... in ischemic stroke patients, today announced the launch of ... the addition of the V 2.0 Soft and V ... of V Series Merci Retrievers® are now approved and ...
... DALLAS, July 20, 2011 ,   ... reports,on The Outlook for Pharmaceuticals for BRIC, Central & ... as well,as E7 countries in its store ... market cover the outlook for pharmaceuticals in,emerging E7 countries as ...
Cached Medicine Technology:Concentric Medical Launches Full Family of Merci Retrievers® in Japan 2Concentric Medical Launches Full Family of Merci Retrievers® in Japan 3ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7) 2ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7) 3ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7) 4
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Lynn Lester as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in business. ... professional women, boasting more than 700,000 members and over ... Lynn Lester with this prestigious award,” said NAPW President ...
(Date:6/1/2015)... 2015 The National Association of ... 2015-2016 inductee into its VIP Woman of the ... distinction for leadership in business. NAPW is the ... boasting more than 700,000 members and over 200 ... Kathy into this exceptional group of professional women,” ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Ticket Down announces ... the NBA Western Conference Finals and now will face the ... will be held at the Oracle Arena in Oakland and ... the 2014-15 National Basketball Association season, the Golden State Warriors ... were a team that learned from their playoff failures from ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Linda Kincaid, age ... had an irregular heartbeat. At first she thought it was ... out it was much more than that. After going to ... Linda admitted she felt afraid about what might happen to ... million Americans are diagnosed with valve disease each year. Valve ...
(Date:6/1/2015)... June 01, 2015 Cambia Health ... today a new, interactive Affordable Care Act (ACA) ... The course, called “Affordable Care Act Expert Series, ... the strategic and consultative insights necessary to effectively ... navigate the impacts of the ACA. , The ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 3Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3
... May 12 ULURU Inc. (Amex: ULU ),today ... 31,2008., For the quarter ended March 31, 2008, ... $0.03 per share, compared to a net,loss of $847,000, ... 2007.,The first quarter 2008 net loss was impacted by ...
... Fish diet to avoid being beaten up, thrown out ... result. , That is the fascinating conclusion of the latest ... of Excellence for Coral Reef Studies and James Cook University, ... team who recently revealed fish use the threat of punishment ...
... FRANKLIN, Mass., May 12 PLC Systems Inc.,(AMEX: ... cardiac and vascular medical,device-based technologies, announced today that ... annual meeting of the European,Association of Percutaneous Cardiovascular ... than 11,000 clinicians and,professionals are expected to attend ...
... Study finds little more than half of patients were checked, ... News) -- The dangers of high blood pressure are well-known, ... pressure screening in doctor,s offices and a low percentage of ... , The Stanford University School of Medicine study, published in ...
... 08:30 a.m. EDT at ... http://www.isispharm.com , CARLSBAD, Calif., ... financial results,for the quarter ended March 31, 2008. The Company finished the ... expense related to stock options, compared to a pro forma NOL,of $18.5 ...
... MARKHAM, ON, May 12 /PRNewswire-FirstCall/ - Innolife Pharma, ... over the previous eight,months regarding the formation of ... in these negotiations where final written terms have ... to the Company,s very first,product acquisition. It should ...
Cached Medicine News:Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 2Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 3Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 4Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 5Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 6Health News:Fish diet to avoid fights 2Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 2Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 3Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 4Health News:High Blood Pressure Still Slipping Past Doctors 2Health News:High Blood Pressure Still Slipping Past Doctors 3Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 2Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 3Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 4Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 5Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 6Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 7Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 8Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 9Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 10Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 11Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 12Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 13Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 14Health News:Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture 2
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... Triiodothyronine (T3) is produced primarily by 5-monodeioination ... the thyroid gland, T3 production occurs at ... that for T4. Release of T3 from ... ~5-8 micrograms/day as compared to 80-100 micrograms/day ...
... a monomeric protein produced and stored in ... is released from the pituitary into the ... regulatory control of hypothalamic somatostatin (SS) and ... frequency of GH release appears to be ...
... monomeric protein produced and stored in somatotrophs ... released from the pituitary into the bloodstream ... control of hypothalamic somatostatin (SS) and GH-releasing ... of GH release appears to be regulated ...
Medicine Products: